Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortality.

Saved in:
Bibliographic Details
Title: Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortality.
Authors: Narendra R; UCSF, San Francisco, California, USA.; UCLA, Los Angeles, California, USA., Lydon EC; UCSF, San Francisco, California, USA., Phan HV; UCSF, San Francisco, California, USA., Spottiswoode N; UCSF, San Francisco, California, USA., Neyton LP; UCSF, San Francisco, California, USA., Diray-Arce J; Precision Vaccines Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Becker PM; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA., Kim-Schulze S; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Hoch A; Precision Vaccines Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Pickering H; UCLA, Los Angeles, California, USA., van Zalm P; Precision Vaccines Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Cairns CB; Drexel University, Tower Health Hospital, Philadelphia, Pennsylvania, USA., Altman MC; Benaroya Research Institute, University of Washington, Seattle, Washington, USA., Augustine AD; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA., Bosinger S; Emory School of Medicine, Atlanta, Georgia, USA., Eckalbar W; UCSF, San Francisco, California, USA., Guan L; Yale School of Public Health, New Haven, Connecticut, USA., Doni Jayavelu N; Benaroya Research Institute, University of Washington, Seattle, Washington, USA., Kleinstein SH; Yale School of Medicine, New Haven, Connecticut, USA., Krammer F; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Maecker HT; Stanford University School of Medicine, Palo Alto, California, USA., Ozonoff A; Precision Vaccines Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Peters B; La Jolla Institute for Immunology, La Jolla, California, USA., Rouphael N; Emory School of Medicine, Atlanta, Georgia, USA., Montgomery RR; Yale School of Medicine, New Haven, Connecticut, USA., Reed E; UCLA, Los Angeles, California, USA., Schaenman J; UCLA, Los Angeles, California, USA., Steen H; Precision Vaccines Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Levy O; Precision Vaccines Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Haller SC; UCSF, San Francisco, California, USA., Erle D; UCSF, San Francisco, California, USA., Hendrickson CM; UCSF, San Francisco, California, USA., Krummel MF; UCSF, San Francisco, California, USA., Matthay MA; UCSF, San Francisco, California, USA., Woodruff P; UCSF, San Francisco, California, USA., Haddad EK; Drexel University, Tower Health Hospital, Philadelphia, Pennsylvania, USA., Calfee CS; UCSF, San Francisco, California, USA., Langelier CR; UCSF, San Francisco, California, USA.; Chan Zuckerberg Biohub San Francisco, San Francisco, California, USA.
Corporate Authors: IMPACC Network, COMET Consortium, EARLI Consortium
Source: JCI insight [JCI Insight] 2025 Nov 10; Vol. 10 (21). Date of Electronic Publication: 2025 Nov 10 (Print Publication: 2025).
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: eCollection Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-3708
DOI:10.1172/jci.insight.195436